FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: MIT Libraries

Citation Tools

This article has a correction. Please see:

Correction: FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial - July 01, 2019

Neurogastroenterology

Original article

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: McIntosh K, Reed DE, Schneider T, et al

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial

Gut 2017;66:1241-1251.